Sponsor or institution
Clinical trials and research at University of Miami School of Medicine
As of November 12, 2026, Find a Trial lists 636 NIH-funded research projects at this institution, with $450.2 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 636NIH research projects
NIH-funded research (newest 40 of 636)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Decoding how GAA repeats in FGF14 cause SCA27B
This project looks at why a specific DNA repeat in the FGF14 gene leads to Spinocerebellar Ataxia 27B in adults.
-
Breathing therapy to help clear brain toxins in older adults who sleep poorly
A small study will test a breathing-based therapy to boost brain toxin clearance in older adults with poor sleep patterns related to Alzheimer’s risk.
-
New retinal imaging to detect brain small vessel disease
A fast, wide-field eye imaging method will measure how tiny retinal blood vessels rhythmically flow to help detect early brain small vessel disease.
-
Understanding the Genetics Behind IBD in South Florida
This grant looks at how genes and the environment come together to influence inflammatory bowel disease in people living in South Florida.
-
MorpHiC Data Resource and Coordinating Center
A national effort to build and share a comprehensive, high-quality catalogue of how human genes affect cell function when they’re turned off, using human cellular models.
-
MorPhiC data hub for gene function in human cells
A data resource and coordinating center will organize and share information about how human genes affect cellular traits when knocked out, helping researchers understand gene functions.
-
Understanding Alzheimer's Genetic Risk in African and Admixed African-American People
A study looks at genetic factors and biomarkers to understand why Alzheimer's disease affects African and admixed African-American communities differently.
-
Genetic Risk for Alzheimer’s in African and admixed African-American communities
Researchers will study how genes influence Alzheimer’s risk in people of African ancestry to better understand why the disease affects diverse communities differently.
-
Genetic Risk for Alzheimer’s Disease in African and African-American Ancestries
Researchers are studying how genes influence Alzheimer’s risk in people of African and mixed African-American backgrounds to improve understanding and prevention.
-
Understanding genetic risk for Alzheimer’s in African and admixed African-American communities
Researchers are studying how genetic factors influence Alzheimer’s risk in people of African ancestry to better understand why dementia affects these groups differently.
-
Genetic risk for Alzheimer’s Disease in African and admixed African-American people
Researchers are studying how genes contribute to Alzheimer's risk in people of African ancestry to improve understanding and potential future care.
-
Understanding genetic risk for Alzheimer’s in African and admixed African-American people
A study will look at how genes influence Alzheimer’s risk in people of African and mixed African-American heritage to improve understanding across diverse populations.
-
Understanding Genetic Risk for Alzheimer’s in African and mixed African-American Ancestries
Researchers will study how genetic factors relate to Alzheimer’s in people of African and mixed African-American backgrounds to improve understanding and future treatments.
-
Understanding genetic risk for Alzheimer’s in African and admixed African-American communities
This grant explores how genes influence Alzheimer’s risk in people of African and admixed African-American ancestry to improve understanding and potentially guide future care.
-
Understanding genetic risk for Alzheimer’s in African and admixed African-American people
This grant looks at how genes affect Alzheimer’s risk in African and mixed African-American groups to improve understanding and eventually help diverse patients.
-
Understanding how risk factors affect progression of cirrhosis and response to statins in patients with cirrhosis
This project follows people with cirrhosis to see what factors speed up their liver disease and whether statin medicines help prevent worsening.
-
How a genetic change causes ALS/FTD and what we can do about it
Researchers are studying how a genetic repeat in C9orf72 leads to toxic proteins that damage brain cells in ALS and FTD, with the goal of finding new treatments.
-
Understanding why Black and Hispanic Hodgkin lymphoma patients have worse survival
A patient-centered study to uncover social and care factors that contribute to lower survival among Black and Hispanic people with Hodgkin lymphoma across all ages.
-
Project ACCESS: Making HIV/HCV Testing in Syringe Services Programs More Reachable
A large, real-world study tests a team-based approach in syringe services programs to boost HIV testing and linkage to care for people who inject drugs.
-
One-stop tele-health concierge to improve PrEP use for people who inject drugs
A telehealth and community-based program tests how to help people who inject drugs start and stick with long-acting PrEP through syringe services programs.
-
READD-ADSP: Building a Global Genetic Resource to Understand Alzheimer’s in Diverse Populations
A large-scale project to create a global genetic resource to study Alzheimer’s disease in people of African, Afro-American, and Hispanic/Latino ancestry, helping researchers uncover why risk differs across groups.
-
READD-ADSP: Building a Genetic Resource to Understand Alzheimer’s in African and Hispanic/Latino Communities
A big, shared genetic resource is being created to study why Alzheimer’s disease affects people of African and Hispanic/Latino ancestry differently.
-
READD-ADSP: Building a diverse genetic resource to understand Alzheimer’s in African and Hispanic/Latino populations
A large, patient-focused genetics project will recruit and study 13,000 people to understand how genes and ancestry affect Alzheimer’s risk across diverse populations.
-
READD-ADSP: Building a Genetic Resource to Understand Alzheimer's in African and Hispanic/Latino Populations
A large, patient-focused genetic program aims to create a shared resource to study Alzheimer’s disease in African, African American, and Hispanic/Latino communities to improve understanding of risk and biology.
-
READD-ADSP: Building a diverse genetic resource for Alzheimer’s disease
A large, diverse group of people will give DNA and health information to help us understand how genetics influence Alzheimer’s across different populations.
-
READD-ADSP: Building a genetic resource to understand Alzheimer's in diverse populations
This NIH grant aims to create a large, diverse genetic resource to study why Alzheimer's affects people differently across African, African American, and Hispanic/Latino populations.
-
READD-ADSP: Building a genetic resource to understand Alzheimer's risk in African, African American, and Hispanic/Latino groups
This grant plans to create a large, shared genetic resource to study why Alzheimer's disease affects people of African, African American, and Hispanic/Latino ancestry differently and to help tailor future prevention and treatment efforts.
-
READD-ADSP: Building a genetic resource to study Alzheimer's in diverse populations
A large, diverse group of people will be enrolled and studied to understand how genetics influence Alzheimer's disease across African, African American, and Hispanic/Latino populations.
-
READD-ADSP: Building a big genetic resource to study Alzheimer’s in diverse populations
A large research effort aims to create a shared genetic resource to understand how Alzheimer’s disease affects people of African and Hispanic/Latino ancestry and how genetic factors like APOE influence risk.
-
TMEM106B genetics and pathology in Alzheimer’s and related diseases
Aims to understand how TMEM106B genetic variants and filaments relate to Alzheimer’s disease, FTLD, and LATE so patients and families may benefit from clearer biology and future therapies.
-
Origins of Alzheimer’s Risk in African Americans
A study to better understand why Alzheimer’s disease risk differs in African American people and how genetics and ancestry influence it.
-
Origins of Alzheimer’s risk in African Americans
A study to understand why Alzheimer’s disease risk differs in African American people and how ancestry and environment contribute to the disease.
-
Alzheimer’s risk in African Americans: uncovering genetic clues
Aims to learn how genetic factors contribute to Alzheimer's risk in African American communities to improve understanding and prevention.
-
Racial differences in breast cancer: how genetics and lifestyle affect tumors
A small, patient-focused study will look at how genes and everyday factors influence breast cancer in African American and African Zambian women.
-
All of Us Enrollment Center: Connecting More People to Precision Health
A nationwide effort to enroll and engage diverse adults in a big health study so researchers can tailor future treatments.
-
Understanding FTLD/FTD and ALS biology to find treatments
A research grant from NIH aims to uncover how frontotemporal lobar degeneration relates to ALS and to identify new biomarkers and therapeutic targets that could help people with these conditions.
-
Biomarkers in Type 1 Diabetes risk and progression for people at risk
A study to identify blood biomarkers that help predict who will develop or progress in Type 1 diabetes among people at risk.
-
How the eye's light-sensing cells connect to other retinal cells
This work looks at molecules that help rod and cone photoreceptors make correct connections so people with inherited synaptic vision problems might benefit.
-
Regulation of GPCR Signals in Brain Reward and Pain Pathways
A study in people studying how brain receptors linked to pain and addiction interact, with a focus on how this might influence substance use and analgesic effects.
-
Engineered probiotics to help long-term AAV-delivered antibody therapy
AIM: test if specially designed probiotics can teach the body’s immune system to tolerate AAV-delivered antibodies to HIV, potentially enabling lasting protection.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.